Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT was delisted on the 2nd of December, 2024.
35 hedge funds and large institutions have $9.68M invested in Oncternal Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
9% less capital invested
Capital invested by funds: $10.6M → $9.68M (-$964K)
13% less funds holding
Funds holding: 40 → 35 (-5)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less call options, than puts
Call options by funds: $12K | Put options by funds: $24K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$9.94K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$8.95K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.95K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.95K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$39.8K |
| 2 |
Morgan Stanley
New York
|
-$38.8K |
| 3 |
Millennium Management
New York
|
-$37K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29.8K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Stifel Financial
St. Louis,
Missouri
| $7K | – | – | – |
|
|
BRWM
27
B. Riley Wealth Management
Memphis,
Tennessee
| $6K | – | – | – |
|
28
Citigroup
New York
| $4K | -$3.98K | -4 | -44% |
|
|
BJ
29
BlackRock Japan
Tokyo,
Japan
| $4K | – | – | – |
|
|
TDC
30
Thompson Davis & Co
Richmond,
Virginia
| $4K | – | – | – |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $3K | – | – | – |
|
32
Simplex Trading
Chicago,
Illinois
| $2K | – | – | – |
|
33
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
|
TCM
34
TD Capital Management
Memphis,
Tennessee
| $1K | – | – | – |
|
35
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
36
Millennium Management
New York
| – | -$37K | -36 | Closed |
|
|
37
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$29.8K | -30 | Closed |
|
|
38
AQR Capital Management
Greenwich,
Connecticut
| – | -$29K | -29 | Closed |
|
|
SIM
39
Spark Investment Management
New York
| – | -$23K | -24 | Closed |
|
40
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$17K | -17 | Closed |
|
ONCT Hedge Fund Activity: Q1 2015 in Review
35 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q1 2015, worth a combined $9.68M — down 9.1% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ONCT and 0 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $9.94K. The largest seller was Virtu KCG Holdings, cutting an estimated $39.8K.
- 35 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q1 2015, down from 40 in Q4 2014.
- Funds reported $9.68M of Oncternal Therapeutics, Inc. Common Stock stock for Q1 2015, down 9.1% quarter-over-quarter.
- 0 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q1 2015 and 5 closed out, a net change of -5 holders.
- The largest Oncternal Therapeutics, Inc. Common Stock buyer in Q1 2015 was BlackRock Institutional Trust, an estimated $9.94K added.
- The largest Oncternal Therapeutics, Inc. Common Stock seller in Q1 2015 was Virtu KCG Holdings, an estimated $39.8K sold.
Based on aggregated 13F filings for Q1 2015.